[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. - Wikidata - wikimedia - TriplyDB

[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates.

[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates.

http://www.wikidata.org/entity/Q44735126

about

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 Imaging radiation response in tumor and normal tissue.Oncologic Angiogenesis Imaging in the clinic---how and why.Preclinical molecular imaging of tumor angiogenesis.Anatomical and molecular imaging of skin cancer 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.Combination of an Integrin-Targeting NIR Tracer and an Ultrasensitive Spectroscopic Device for Intraoperative Detection of Head and Neck Tumor Margins and Metastatic Lymph Nodes.Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis.[(68)Ga]NODAGA-RGD - Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography.First in-human radiation dosimetry of 68Ga-NODAGA-RGDyK Developing Targeted Hybrid Imaging Probes by Chelator Scaffolding Integrin αvβ3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy.Molecular imaging of gliomas with PET: opportunities and limitations.Molecular imaging of angiogenesis with SPECT.Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.Cyclic RGD Peptides Incorporating Cycloalkanes: Synthesis and Evaluation as PET Radiotracers for Tumor Imaging.Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides Click chemistry for (18)F-labeling of RGD peptides and microPET imaging of tumor integrin alphavbeta3 expression A radiofluorinated divalent cystine knot peptide for tumor PET imaging.PET imaging of αvβ₃ integrin expression in tumours with ⁶⁸Ga-labelled mono-, di- and tetrameric RGD peptides.Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1.Exploring new near-infrared fluorescent disulfide-based cyclic RGD peptide analogs for potential integrin-targeted optical imaging.Positron emission tomography imaging of cancer biology: current status and future prospects Integrin alpha v beta 3-targeted imaging of lung cancer.F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT Atherosclerotic plaque uptake of a novel integrin tracer ¹⁸F-Flotegatide in a mouse model of atherosclerosis.Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.F-18 Labeled RGD Probes Based on Bioorthogonal Strain-Promoted Click Reaction for PET Imaging.The next generation of positron emission tomography radiopharmaceuticals in oncology.PET Imaging of Integrin Positive Tumors Using F Labeled Knottin Peptides.18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.The potential of positron-emission tomography to study anticancer-drug resistance.Stroma targeting nuclear imaging and radiopharmaceuticals.One-step and one-pot-two-step radiosynthesis of cyclo-RGD-(18)F-aryltrifluoroborate conjugates for functional imaging.

P2860

Q24805375-9CCDE3CB-594E-40F1-BD74-3F8A93F63A88 Q26771417-C032253E-6A3D-402C-8F89-94782B039630 Q26798266-1F35A1CA-C8F7-4B60-A94E-95204E1F90B8 Q30472751-1E5DA203-B06D-48C4-972B-F4ED808547D6 Q30475818-4C8E73D4-B170-47ED-84A2-81D3E27D1DA9 Q30476227-260F8731-239A-44DA-A3EC-EB133E3EF565 Q30497615-B6BC0052-0CDA-4019-8ED6-25CD4C4F6E7D Q30820507-88ED711B-FD98-4DB1-B2B4-A37CEDE95EAC Q30981267-16CA9435-5249-4E61-8FED-84BA0D290DAC Q31095114-12CEEE10-DB29-4686-A19A-EC68F582C050 Q33237917-164B2B39-06DB-4652-B3D5-B5058A21CC5F Q33574585-C0AFCE94-702D-4C81-8783-32C91D96F716 Q33704623-049CBE6A-A233-49F6-8738-2654AF2C3302 Q33827092-3F7B661D-1C4C-4C29-BED1-0447C2DF1A9F Q33851309-A20C66C6-85EF-451C-9C80-C767D5A050C6 Q33961188-ED927ADC-1338-4ADF-923C-3F8AF4FD4D4D Q34040149-DFBC89AA-84C1-4F93-AAFE-D915185BBB64 Q34159304-61E1D9E9-F11E-4E0A-89C8-7F74B280BEAB Q34159603-7CB4A9E8-2119-4F26-B3B7-33FD619A4251 Q34162650-2679AA7C-F632-4CB9-8FC5-AB422313335A Q34196969-91564372-5955-4B48-AA86-96E89BA6C39F Q34282895-BB39E630-47BA-47EE-9873-83C389C0A282 Q34416172-9F50994F-169D-48D9-95CD-7D8B536CD0EB Q34420335-8C3E28B5-E597-47B8-B5FA-5F70CFEA2838 Q34612830-5E7EA0D9-05B6-428E-B64E-C27F8C942F71 Q34669572-E30551D1-7035-4E56-BA40-9C416B6FE25B Q34697688-4943312B-1F4B-484D-8D99-64659985F0CA Q34768362-6D6642A3-67E5-4F39-8DEC-8C3EDF97E609 Q34912606-1AFC71EF-23BB-4840-A1D3-AFCA08D2D8B3 Q34912643-2FE2294E-4457-45E2-81DE-87FF2694698C Q35047646-9C075AFD-D134-4067-BDD2-5B402FB4BF4E Q35062113-AFE49395-769F-45BA-BEA2-807BCC28B39E Q35109294-51EB0712-5064-48E9-AF53-CADB3A942B8B Q35379070-C66DC0C0-A8F7-482B-B9CF-098AD3A9E1A9 Q35525690-36765A7C-F65B-42BA-ADFE-6DF6FB4B58DA Q35641937-6D976177-16AF-42BF-AD99-7D3227B069FC Q35784807-D1BC56BB-620C-424A-ADFC-2BFDA5BC51D8 Q35788120-182B4029-CA06-4C54-8997-2050F4C85BA5 Q35999606-F865C01B-85E9-442F-864F-17CC2B622262 Q36533804-62401F95-C68E-4820-9BE2-913A96E8AAA1

P2860

[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates.

http://www.wikidata.org/entity/Q44735126

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

[18F]Galacto-RGD: synthesis, r ...... and radiation dose estimates.

@en

[18F]Galacto-RGD: synthesis, r ...... and radiation dose estimates.

@nl

type

label

[18F]Galacto-RGD: synthesis, r ...... and radiation dose estimates.

@en

[18F]Galacto-RGD: synthesis, r ...... and radiation dose estimates.

@nl

prefLabel

[18F]Galacto-RGD: synthesis, r ...... and radiation dose estimates.

@en

[18F]Galacto-RGD: synthesis, r ...... and radiation dose estimates.

@nl

P1433

Q44735126-305DC848-B336-4B42-96D1-FAFE0A38667B

P1476

Q44735126-F560449F-DC64-49BD-B28E-EB53E5314C7F

P2093

Q44735126-19BAABEF-2E60-4DD5-AB86-C7EBA0BEFBEC

Q44735126-2CE87405-D8A1-4BA7-A9FC-46F0DF289FE4

Q44735126-55529141-06F9-4033-B229-69A192417A50

Q44735126-AC5A5F47-EE57-4FEC-9EF1-0A8FD9008B88

Q44735126-CDC72DCE-352D-450D-B987-DC1291535A12

P304

Q44735126-888B3CE6-3908-450D-86C0-AB4E12A579CF

P31

Q44735126-8C0F0B9E-4858-44DC-83C8-D018A8429A22

P356

Q44735126-24E542FF-1231-47E4-96BC-F1DCB4FCD025

P433

Q44735126-145B2364-0687-423E-9495-CE2C74CA3B8F

P478

Q44735126-1E2F2FF0-1AC6-4D12-9245-0C5A43857116

P50

Q44735126-EB4B5A63-3197-4A60-A9F4-1DEA1B73DCFC

Q44735126-EFF58642-52B8-41C1-A23B-9BAD0066528A

P577

Q44735126-C1E40AAE-53B8-44B4-B557-9F6135D13F8A

P5875

Q44735126-03613C40-E204-4679-BDBE-A04539160B3A

P698

Q44735126-C4A725A0-B7D3-4817-BF88-0E9E60940E91

P356

P1433

Bioconjugate Chemistry

P1476

[18F]Galacto-RGD: synthesis, r ...... and radiation dose estimates.

@en

P2093

Christian Mang

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Wester

http://www.w3.org/2001/XMLSchema#string

Horst Kessler

http://www.w3.org/2001/XMLSchema#string

Roland Haubner

http://www.w3.org/2001/XMLSchema#string

Wolfgang A Weber

http://www.w3.org/2001/XMLSchema#string

P304

61-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/BC034170N

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Markus Schwaiger

Bertrand Kuhnast

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8910572

http://www.w3.org/2001/XMLSchema#string

P698

14733584

http://www.w3.org/2001/XMLSchema#string